| Stage | RXO | % of rev | CPAY | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.9B | 100.00% | $1.3B | 100.00% | RXO ×1.40 |
| Gross profit | $333M | 17.80% | $1.1B | 79.45% | CPAY +61.6pp |
| Operating income | $17M | 0.91% | $472M | 35.28% | CPAY +34.4pp |
| Pre-tax income | $6M | 0.32% | $345M | 25.75% | CPAY +25.4pp |
| Net income | $3M | 0.16% | $252M | 18.81% | CPAY +18.6pp |
| Stage | RXO | CPAY | Gap · A − B |
|---|---|---|---|
| Revenue | $1.9B100.00% | $1.3B100.00% | RXO ×1.40 |
| Gross profit | 17.80%$333M | 79.45%$1.1B | CPAY +61.6pp |
| Operating income | 0.91%$17M | 35.28%$472M | CPAY +34.4pp |
| Pre-tax income | 0.32%$6M | 25.75%$345M | CPAY +25.4pp |
| Net income |
| 0.16%$3M |
| 18.81%$252M |
| CPAY +18.6pp |